Frontlight ResearchEarly access
Trial site
Hammersmith Hospital, Imperial College Healthcare NHS Trust
- 13running trials
- 2closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Heart failure2 trials
- Sickle cell disease2 trials
- ANCA-associated vasculitis1 trial
- Antiphospholipid syndrome1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Giant cell arteritis1 trial
- High blood pressure1 trial
- Lupus (SLE)1 trial
- and 5 more
- Phase
- Phase 24 trials
- Phase 32 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Active, not recruiting5 trials
- Completed2 trials
- Lead sponsor
- Pfizer2 trials
- CSL Behring1 trial
- Enliven Therapeutics1 trial
- Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)1 trial
- Imperial College London1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Recruiting
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Sickle cell disease2 recruiting
- Chronic myeloid leukaemia1 recruiting
- Giant cell arteritis1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Polymyalgia rheumatica1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026